Volume 17, Issue 8, Pages (August 2010)

Slides:



Advertisements
Similar presentations
Volume 22, Issue 5, Pages (May 2015)
Advertisements

Purple discoloration of the colon found during autopsy: Identification of betanin, its aglycone and metabolites by liquid chromatography–high-resolution.
Volume 22, Issue 5, Pages (May 2015)
Development of Antibiotic Activity Profile Screening for the Classification and Discovery of Natural Product Antibiotics  Weng Ruh Wong, Allen G. Oliver,
Volume 21, Issue 12, Pages (December 2013)
Volume 15, Issue 6, Pages (June 2008)
Brain Region Mapping Using Global Metabolomics
Enzyme Annotation with Chemical Tools
Volume 21, Issue 2, Pages (February 2014)
Volume 21, Issue 7, Pages (July 2014)
Volume 21, Issue 7, Pages (July 2014)
Miglena Manandhar, John E. Cronan  Chemistry & Biology 
Volume 19, Issue 5, Pages (May 2012)
Volume 24, Issue 8, Pages e7 (August 2017)
Volume 22, Issue 5, Pages (May 2015)
An Enzyme that Regulates Ether Lipid Signaling Pathways in Cancer Annotated by Multidimensional Profiling  Kyle P. Chiang, Sherry Niessen, Alan Saghatelian,
Volume 20, Issue 4, Pages (April 2013)
Proteomic Approaches to Cancer Biomarkers
Jacqueline L. Blankman, Gabriel M. Simon, Benjamin F. Cravatt 
Nat. Rev. Nephrol. doi: /nrneph
Volume 24, Issue 10, Pages e7 (October 2017)
Exploring Metabolic Pathways and Regulation through Functional Chemoproteomic and Metabolomic Platforms  Daniel Medina-Cleghorn, Daniel K. Nomura  Chemistry.
A Photoreactive Small-Molecule Probe for 2-Oxoglutarate Oxygenases
A Revised Pathway Proposed for Staphylococcus aureus Wall Teichoic Acid Biosynthesis Based on In Vitro Reconstitution of the Intracellular Steps  Stephanie.
Volume 22, Issue 7, Pages (July 2015)
Visualization of Redox-Controlled Protein Fold in Living Cells
Redesign of a Dioxygenase in Morphine Biosynthesis
Urine metabolomics using liquid chromatography quadrupole time-of-flight mass spectrometry indicates common markers of disease in alkaptonuria and idiopathic.
Volume 20, Issue 12, Pages (December 2013)
Volume 15, Issue 6, Pages (March 2005)
How Chemoproteomics Can Enable Drug Discovery and Development
Development of Antibiotic Activity Profile Screening for the Classification and Discovery of Natural Product Antibiotics  Weng Ruh Wong, Allen G. Oliver,
A Metabolomic View of Staphylococcus aureus and Its Ser/Thr Kinase and Phosphatase Deletion Mutants: Involvement in Cell Wall Biosynthesis  Manuel Liebeke,
A Sensitive Gas Chromatography-Mass Spectrometry Assay Reveals Increased Levels of Monohydroxyeicosatetraenoic Acid Isomers in Human Plasma After Extracorporeal.
Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes  Jessica P.
Andy Weiss, Renee M. Fleeman, Lindsey N. Shaw  Cell Chemical Biology 
Volume 25, Issue 3, Pages e3 (March 2018)
Volume 20, Issue 2, Pages (February 2013)
A Subdomain Swap Strategy for Reengineering Nonribosomal Peptides
Volume 22, Issue 11, Pages (November 2015)
Volume 19, Issue 2, Pages (February 2012)
Is Proteomics the New Genomics?
Volume 17, Issue 9, Pages (November 2016)
Volume 19, Issue 5, Pages (May 2012)
Volume 17, Issue 4, Pages (April 2010)
An Artificial Pathway to 3,4-Dihydroxybenzoic Acid Allows Generation of New Aminocoumarin Antibiotic Recognized by Catechol Transporters of E. coli  Silke.
Volume 15, Issue 5, Pages (May 2008)
Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism  Jonathan Z. Long, Daniel.
Jae Won Chang, Daniel K. Nomura, Benjamin F. Cravatt 
Volume 24, Issue 12, Pages e5 (December 2017)
Volume 20, Issue 6, Pages (June 2013)
Volume 22, Issue 7, Pages (July 2015)
Volume 21, Issue 8, Pages (August 2014)
One Enzyme, Three Metabolites: Shewanella algae Controls Siderophore Production via the Cellular Substrate Pool  Sina Rütschlin, Sandra Gunesch, Thomas.
Volume 19, Issue 7, Pages (July 2012)
Volume 22, Issue 5, Pages (May 2015)
Volume 23, Issue 6, Pages (June 2016)
Volume 18, Issue 12, Pages (December 2011)
The Coming Age of Complete, Accurate, and Ubiquitous Proteomes
Volume 19, Issue 11, Pages (November 2012)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Volume 17, Issue 8, Pages (August 2010)
CLOCK Acetylates ASS1 to Drive Circadian Rhythm of Ureagenesis
Volume 18, Issue 1, Pages (January 2011)
Volume 15, Issue 9, Pages (September 2008)
Volume 20, Issue 10, Pages (October 2013)
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes  Jessica P.
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Volume 21, Issue 3, Pages (March 2014)
Presentation transcript:

Volume 17, Issue 8, Pages 831-840 (August 2010) The Glycerophospho Metabolome and Its Influence on Amino Acid Homeostasis Revealed by Brain Metabolomics of GDE1(−/−) Mice  Florian Kopp, Toru Komatsu, Daniel K. Nomura, Sunia A. Trauger, Jason R. Thomas, Gary Siuzdak, Gabriel M. Simon, Benjamin F. Cravatt  Chemistry & Biology  Volume 17, Issue 8, Pages 831-840 (August 2010) DOI: 10.1016/j.chembiol.2010.06.009 Copyright © 2010 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2010 17, 831-840DOI: (10. 1016/j. chembiol. 2010 Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 1 GDE1(−/−) Brains Contain Markedly Elevated Levels of Multiple Metabolites (A) Mass ion peak intensity measurements from GDE1(+/+) versus (−/−) brains. Data are derived from untargeted metabolite profiling experiments performed in the negative ionization mode. Red spots represent m/z ions that are significantly elevated in GDE1(−/−) brains (in each case, fold-change >10) and their m/z values are displayed. Isotopologs, adducts, and ions produced by in-source fragmentation were manually removed for clarity. (B) Extracted ion chromatograms (EICs) from individual LC-MS runs of GDE1(+/+) and (−/−) brain metabolomes. The retention times for the relevant peaks are shown in minutes. See also Figure S1 and Tables S1 and S4. Chemistry & Biology 2010 17, 831-840DOI: (10.1016/j.chembiol.2010.06.009) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 2 Structural Characterization of GDE1-Regulated Brain Metabolites (A, C, and E) Chromatographic behavior on normal-phase LC of synthetic GroPIns, GroPSer, and GroPGate compared to the natural metabolites elevated in brains of GDE1(−/−) mice. Insets show observed and calculated masses (o.m. and c.m., respectively) for natural metabolites, as measured by quadrupole time-of-flight (QTOF) mass spectrometry (for higher resolution FT-ICR mass-measurements, see Table S4). (B, D, and F) MS/MS spectra showing daughter ions that correspond to the glycerophosphate backbone (m/z 78.95, 96.97, 152.99, 171.00). Endogenous daughter ions matched their synthetic counterparts within 20 ppm which is typical for MS/MS ions obtained via QTOF mass spectrometry. The existence of the inositol (B) and glycerate (C) head-groups was confirmed by diagnostic peaks representing inositol- and dehydrated glycerate-phosphate, respectively. MS/MS profiles of synthetic (blue) and natural (red) metabolites are shown. See also Figures S1 and  S2 and Tables S2 and S3. Chemistry & Biology 2010 17, 831-840DOI: (10.1016/j.chembiol.2010.06.009) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 3 GroPSer, GroPIns, and GroPGate Are Direct Substrates of GDE1 Membrane preparations from GDE1-transfected COS-7 cells (A and B) or mouse brain samples (C and D) were tested for activity against synthetic GroP metabolites with different head-groups : serine (GroPSer), glycerate (GroPGate), or inositol (GroPIns). Enzyme activity was determined by quantification of the release of free head group (serine, glycerate, and inositol from GroPSer, GroPGate, and GroPIns, respectively) by LC-MS in recombinant GDE1 assays. For mouse brain samples, enzyme activity against GroPSer and GroPGate was measured in the same way, and, for GroPIns, was determined by measuring reductions in consumed substrate (due to the presence of high background isobaric mass signals for inositol in brain samples). All assays were performed with n = 3, ∗∗p < 0.01; ∗p < 0.05, Student's t test. (B) and (D) show western blots using an anti-Myc antibody (B) or rabbit polyclonal antibodies raised against recombinant mouse GDE1 (D). Chemistry & Biology 2010 17, 831-840DOI: (10.1016/j.chembiol.2010.06.009) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 4 GDE1 Regulates Free Serine Levels in Mouse Brain (A) Levels of serine are reduced by 1.6-fold in GDE1(−/−) brains. Data represent the average of six independent experiments per group ±SE. ∗p < 0.05. (B) Derivitization with BocPheOSu enables resolution of L- and D-serine via reverse-phase chromatography. (C) BocPheOSu derivitization of brain metabolomes reveals that both L- and D- serine levels are reduced by a similar magnitude in GDE1(−/−) brains. ∗p < 0.05 for both enantiomers. (D) Working model for the role of GDE1 in serine metabolism. Phosphatidylserine (PtdS) which is exclusively located on the inner leaflet of the plasma membrane is deacylated by A- or B-type phospholipases (PLA/B) whereupon the resulting GroPSer is released into the cytosol and is transported across the plasma membrane by a putative GroPSer transporter. Subsequently, extracellular GroPSer is exposed to the catalytic domain of GDE1 resulting in the release of serine and glycerol-3-phosphate. In the absence of GDE1, GroPSer accumulates, resulting in corresponding reductions in serine. See also Figure S3. Chemistry & Biology 2010 17, 831-840DOI: (10.1016/j.chembiol.2010.06.009) Copyright © 2010 Elsevier Ltd Terms and Conditions